Home › Funds › BCK CAPITAL MANAGEMENT LP › FOLD
BCK CAPITAL MANAGEMENT LP position in FOLD
AMICUS THERAPEUTICS INC
BCK CAPITAL MANAGEMENT LP reported holding 20,000 shares of FOLD (AMICUS THERAPEUTICS INC) in its Q1 2026 13F filing — a position valued at US$289K, representing 1.26% of its reported portfolio and ranking #21 among its reported holdings. BCK CAPITAL MANAGEMENT LP first reported this position in Q1 2026.
Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR
How BCK CAPITAL MANAGEMENT LP's FOLD position evolved
BCK CAPITAL MANAGEMENT LP first disclosed a stake in FOLD in Q1 2026 at 20,000 shares (US$289K).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 20.00K | $289.20K | New |
About FOLD and 13F data
FOLD (AMICUS THERAPEUTICS INC) is a company whose sector is not yet classified in our data. 2 other funds we track also report a position in FOLD. Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
More on BCK CAPITAL MANAGEMENT LP
FAQ
How long has BCK CAPITAL MANAGEMENT LP held FOLD?
BCK CAPITAL MANAGEMENT LP has disclosed FOLD holdings in 1 of the last 1 reported quarters, going back to Q1 2026.
What is BCK CAPITAL MANAGEMENT LP's current position in FOLD?
As of Q1 2026, BCK CAPITAL MANAGEMENT LP holds 20.00K shares of FOLD (AMICUS THERAPEUTICS INC), valued at $289.20K, representing 1.26% of its reported portfolio and ranking #21.
Has BCK CAPITAL MANAGEMENT LP been buying or selling FOLD?
In the latest 13F filing (Q1 2026), BCK CAPITAL MANAGEMENT LP newly opened its position in FOLD.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.